A new protocol (THIS and FAT) for the treatment of filler-induced vascular occlusion: a case series
IntroductionHyaluronic acid (HA) fillers are generally safe; however, the most significant complication is vascular occlusion. Several therapeutic protocols have been proposed for managing ischemia. De Lorenzi introduced the HDPH protocol, which uses a minimum of 500 IU of hyaluronidase (HYAL) per i...
Saved in:
| Main Authors: | Shahriar Nazari, Nabil Fakih-Gomez, Nima Hadadian, Foroohe Bayat, Behnam Bohlouli, Cristina Muñoz-Gonzalez, Mohammad Reza Pourani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1585983/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative in-vitro degradation of hyaluronic acids exposed to different hyaluronidase enzymes
by: Marcelo Germani, et al.
Published: (2025-01-01) -
Reversible vision loss following nonsurgical filler rhinoplasty
by: Vladimir A. Sheptulin, et al.
Published: (2022-12-01) -
Complications associated with the use of hyaluronic acid and their management - a literature review
by: Magdalena Turczynowicz, et al.
Published: (2025-04-01) -
Vascular occlusion due to blunt-tipped cannula: Case report and simplifying best practices
by: Jackson Margolis, BA, et al.
Published: (2025-01-01) -
Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets
by: Jiamin Lu, et al.
Published: (2025-07-01)